Treace Medical Concepts price to book ratio TMCI
Market value divided by the book value of the company's net assets, since 2021.
- Today, Oct 23, 2026
- 4.1×
- 5-year median
- 5.1×
- Against its 5-year history
- 33rd
- percentile: 0 is its lowest day, 100 its highest
- 5-year range
- 0.9× to 28.1×
- Peer median
- 2.6×
Treace Medical Concepts' price to book ratio is 4.1× as of Oct 23, 2026.
That is below its 5-year median of 5.1×, lower than on 67% of days in the last 5 years.
Over that time it ranged from 0.9× in Mar 2026 to 28.1× in Apr 2023.
The median for 10 medical instruments and supplies stocks of a similar size is 2.6×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 4.1× | 0.9× | 4.6× |
| 2025 | 1.7× | 1.7× | 6.1× |
| 2024 | 4.1× | 2.1× | 6.9× |
| 2023 | 5.7× | 2.8× | 28.1× |
| 2022 | 20.5× | 9.1× | 21.8× |
| 2021 | 10.2× | 9.0× | 15.1× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Treace Medical Concepts' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| TMCITreace Medical Concepts | 4.1× |
| INFUInfuSystem | 4.7× |
| UTMDUtah Medical Products | 1.9× |
| EMBCEmbecta | n/m |
| PDEXPro DEX | 4.2× |
| TCMDTactile Systems Technology | 2.4× |
| MDXGMimedx | 2.6× |
| MOVMovado | 1.4× |
| KEQUKewaunee Scientific | 1.3× |
| IRMDIradimed | 10.8× |
| STAAStaar Surgical | 3.1× |
| Peer median | 2.6× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Treace Medical Concepts
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.